InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,230.80
(
-0.01%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
81.91
(
-0.65%
)
Bitcoin
69,925.23
(
-0.29%
)

Replies to post #779 on VYNE Therapeutics Inc (VYNE)

Replies to #779 on VYNE Therapeutics Inc (VYNE)

Tzr250rg

06/17/22 12:50 PM

#780 RE: Tzr250rg #779

News out.

June 17, 2022

8:00 am ET


*VYNE Therapeutics Completes Enrollment In Phase 2a Trial Of FMX114 For Treatment Of Mild-To-Moderate Atopic Dermatitis
Benzinga